Synteract Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Synteract's estimated annual revenue is currently $135.6M per year.(i)
  • Synteract's estimated revenue per employee is $438,916

Employee Data

  • Synteract has 309 Employees.(i)
  • Synteract grew their employee count by -17% last year.

Synteract's People

NameTitleEmail/Phone
1
VP Quality AssuranceReveal Email/Phone
2
VP FinanceReveal Email/Phone
3
General CounselReveal Email/Phone
4
SVP, Clinical DevelopmentReveal Email/Phone
5
VP Project ManagementReveal Email/Phone
6
VP, Business DevelopmentReveal Email/Phone
7
Clinical Team Management Associate DirectorReveal Email/Phone
8
Director, Clinical Team ManagementReveal Email/Phone
9
Senior Director, HR OperationsReveal Email/Phone
10
Associate Director, Clinical Project CentralReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Synteract?

Synteract is a leading provider of clinical research services to the pharmaceutical and biotech industry. We assist firms in the clinical trials process from patient enrollments to FDA submission. Synteract is focused on reducing the time, risk, and cost of bringing new products to a highly competitive market while providing the highest degree of service and integrity.

keywords:N/A

N/A

Total Funding

309

Number of Employees

$135.6M

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Synteract News

2022-04-20 - Phase I – IV Clinical Development Services Market Analysis 2022 to ...

... GVI CDS, Parexel, Clinical Leader, Thermo Fisher Scientific, LabCorp, Worldwide Clinical Trial, CROS NT, Dynakin, Rho, Inc., Synteract,...

2022-04-19 - How Small Biotechs Can Prepare For & Navigate CRO M&As

Spinner J. Syneos Health to acquire Synteract. Outsourcing-Pharma Web Site. Updated October 29, 2020.

2022-03-22 - Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors

... completed the acquisition of Synteract Health, a 700 employee company involved in ~4k clinical trials and 26k trial sites globally,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$85.8M312-2%N/A
#2
$55.5M312-20%$38.6M
#3
$91.1M32150%N/A
#4
$125.1M323-21%$66M
#5
$64.3M343N/AN/A